Literature DB >> 29627187

Severe Cardiac Involvement Is Rare in Patients with Late-Onset Pompe Disease and the Common c.-32-13T>G Variant: Implications for Newborn Screening.

Mrudu Herbert1, Heidi Cope1, Jennifer S Li2, Priya S Kishnani3.   

Abstract

Based on a review of a large patient cohort, published literature, and 3 newborn screening cohorts, we concluded that children diagnosed through newborn screening with late-onset Pompe disease and the common heterozygous c.-32-13T>G variant require frequent cardiac follow-up with electrocardiography for arrhythmias. However, there is limited evidence for performing repeated echocardiography for cardiomyopathy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acid-α-glucosidase; arrhythmia; glycogen storage disease type II; hypertrophic cardiomyopathy

Mesh:

Substances:

Year:  2018        PMID: 29627187     DOI: 10.1016/j.jpeds.2018.02.007

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Variable clinical features and genotype-phenotype correlations in 18 patients with late-onset Pompe disease.

Authors:  Jousef Alandy-Dy; Marie Wencel; Kathy Hall; Julie Simon; Yanjun Chen; Erik Valenti; Jade Yang; Deeksha Bali; Anita Lakatos; Namita Goyal; Tahseen Mozaffar; Virginia Kimonis
Journal:  Ann Transl Med       Date:  2019-07

2.  Phenotypic implications of pathogenic variant types in Pompe disease.

Authors:  Manuel A Viamonte; Stephanie L Filipp; Zara Zaidi; Matthew J Gurka; Barry J Byrne; Peter B Kang
Journal:  J Hum Genet       Date:  2021-05-11       Impact factor: 3.172

3.  A Newborn Screening, Presymptomatically Identified Infant With Late-Onset Pompe Disease: Case Report, Parental Experience, and Recommendations.

Authors:  Raymond Y Wang
Journal:  Int J Neonatal Screen       Date:  2020-03-14

4.  GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry.

Authors:  Arnold J J Reuser; Ans T van der Ploeg; Yin-Hsiu Chien; Juan Llerena; Mary-Alice Abbott; Paula R Clemens; Virginia E Kimonis; Nancy Leslie; Sonia S Maruti; Bernd-Jan Sanson; Roberto Araujo; Magali Periquet; Antonio Toscano; Priya S Kishnani
Journal:  Hum Mutat       Date:  2019-08-07       Impact factor: 4.878

5.  Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants.

Authors:  Barbara K Burton; Joel Charrow; George E Hoganson; Julie Fleischer; Dorothy K Grange; Stephen R Braddock; Lauren Hitchins; Rachel Hickey; Katherine M Christensen; Daniel Groepper; Heather Shryock; Pamela Smith; Rong Shao; Khaja Basheeruddin
Journal:  Int J Neonatal Screen       Date:  2020-01-21

6.  Newborn Screening for Pompe Disease: Pennsylvania Experience.

Authors:  Can Ficicioglu; Rebecca C Ahrens-Nicklas; Joshua Barch; Sanmati R Cuddapah; Brenda S DiBoscio; James C DiPerna; Patricia L Gordon; Nadene Henderson; Caitlin Menello; Nicole Luongo; Damara Ortiz; Rui Xiao
Journal:  Int J Neonatal Screen       Date:  2020-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.